Targeting potential drivers of COVID-19: Neutrophil extracellular traps

Cited by (1,000)

Items 901–1,000 of 1,000

1. Identification of hematological and inflammatory parameters associated with disease severity in hospitalized patients of COVID-19
   Sana Ahuja, Avneesh Malviya · 2022 · Journal of Family Medicine and Primary Care
2. Role of the renin-angiotensin system in NETosis in the coronavirus disease 2019 (COVID-19)
   Qingguang Zhang, Shuang Ling, Kaili Hu, Jun Liu, Jin‐Wen Xu · 2022 · Biomedicine & Pharmacotherapy
3. Serum neutrophil gelatinase-associated lipocalin concentrations are significantly associated with the severity of COVID-19 in pregnant patients
   Esra Can, Süleyman Cemil Oğlak, Fatma Ölmez, Huri Bulut · 2022 · Saudi Medical Journal
4. Abrogation of neutrophil inflammatory pathways and potential reduction of neutrophil-related factors in COVID-19 by intravenous immunoglobulin
   Jorge Adrian Masso-Silva, George Sakoulas, Jarod Olay, Victoria M. Groysberg, Matthew Geriak, Victor Nizet, Laura E. Crotty Alexander, Angela Meier · 2022 · Frontiers in Immunology
5. Are Antisense Long Non-Coding RNA Related to COVID-19?
   Eman A.E. Badr, Ibrahim Eltantawy El Sayed, Mohanad Kareem Razak Alasdi Gabber, Eman Abdel-Rahim Ghobashy, Abdullah Godran Al-Sehemi, H. Algarni, Yasser Elghobashy · 2022 · Biomedicines
6. Two in one: Overlapping CT findings of COVID-19 and underlying lung diseases
   Gamze Durhan, Selin Ardalı Düzgün, Yusuf Baytar, Meltem Gülsün Akpınar, Figen Demirkazık, Orhan Macit Arıyürek · 2022 · Clinical Imaging
7. A specific molecular signature in SARS-CoV-2–infected kidney biopsies
   Pierre Isnard, Paul Vergnaud, Serge Garbay, Matthieu Jamme, Maëva Eloudzeri, Alexandre Karras, Dany Anglicheau, Valérie Galantine, Arwa Jalal Eddine, Clément Gosset et al. · 2023 · JCI Insight
8. Exaggerated neutrophil extracellular trap formation in Kawasaki disease: a key phenomenon behind the outbreak in western countries?
   Kouhei Yamashita, Akifumi Takaori‐Kondo, Kiyomi Mizugishi · 2020 · Annals of the Rheumatic Diseases
9. Formation and Clearance of NETs in Health and Disease
   Jasmin Knopf, Aparna Mahajan, Luis Enrique Munoz, Martin Herrmann i · 2022 · Cells
10. Single-Cell RNA Sequencing Reveals Alterations in Patient Immune Cells with Pulmonary Long COVID-19 Complications
    Kristīne Vaivode, Rihards Saksis, Helēna Daiga Litvina, Helvijs Niedra, Marta Līva Spriņģe, Una Krūmiņa, Jānis Kloviņš, Vita Rovīte · 2024 · Current Issues in Molecular Biology
11. Predictors of Intensive Care Unit Admission among Hospitalized COVID-19 Patients in a Large University Hospital in Tehran, Iran
    Hossein Hatami, Hussein Soleimantabar, Mehrdad Ghasemian, Negar Delbari, Shayan Aryannezhad · 2021 · Journal of Research in Health Sciences
12. Immunological aspects of coronavirus disease caused by SARS-CoV-2
    Абакушина Елена Вячеславовна · 2020 · Genes and Cells
13. Potential for Manuka honey‐inspired therapeutics to improve the host–biomaterial response
    Evan N. Main, Gary L. Bowlin · 2022 · MedComm – Biomaterials and Applications
14. Myeloid-Derived Suppressor Cells in Cancer and COVID-19 as Associated with Oxidative Stress
    Celia Andrés, José Manuel Pérez de la Lastra, Celia Juan, Francisco J. Plou, Eduardo Pérez‐Lebeña · 2023 · Vaccines
15. Oridonin inhibits inflammation of epithelial cells via dual-targeting of CD31 Keap1 to ameliorate acute lung injury
    Yue Zhao, Hua Jin, Kawai Lei, Li‐Ping Bai, Hudan Pan, Caiyan Wang, Xiaoming Zhu, Yanqing Tang, Zhengyang Guo, Jiye Cai et al. · 2023 · Frontiers in Immunology
16. Uridine Diphosphate Glucose (UDP-G) Activates Oxidative Stress and Respiratory Burst in Isolated Neutrophils
    Fabiana Lairion, Claudio Carbia, Iris Chiesa, Christian Saporito-Magriñá, Natalia Borda, Alberto Lazarowski, Marisa Gabriela Repetto · 2023 · Pharmaceuticals
17. Association of vascular netosis with COVID-19 severity in asymptomatic and symptomatic patients
    Suman Kapoor, Lucia Mihalovičová, Ekaterina Pisareva, Brice Pastor, Alexia Mirandola, Benoit Roch, Joe Bryant, Anna Philip Princy, Salem Chouaı̈b, Alain Roger Thierry · 2024 · iScience
18. Dysregulation of the immune system as a driver of the critical course of the novel coronavirus disease 2019
    Agata Kosmaczewska, Irena Frydecka · 2020 · Polskie Archiwum Medycyny Wewnętrznej
19. On the relationship between BCG coverage and national COVID‐19 outcome: could ‘heterologous’ herd immunity explain why some countries are better off?
    Maria Lerm · 2020 · Journal of Internal Medicine
20. Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease
    Joseph W. Golden, Xiankun Zeng, Curtis R. Cline, Aura R. Garrison, Lauren E. White, Collin J. Fitzpatrick, Steven A. Kwilas, Philip A Bowling, Jimmy O. Fiallos, Joshua L. Moore et al. · 2021 · Journal of General Virology
21. Feasibility Assessment of an Encapsulated Longevity Spinach (Gynura procumbens L.) Extract Plant in Indonesia
    Dewi Tristantini, Heri Setiawan, Leon Lukhas Santoso · 2021 · Applied Sciences
22. Identification of significant alteration genes, pathways and TFs induced by LPS in ARDS via bioinformatical analysis
    Weina Lu, Ran Ji · 2021 · BMC Infectious Diseases
23. Severe Type of COVID-19: Pathogenesis, Warning Indicators and Treatment
    Ke Shi, Yao Liu, Qun Zhang, Chongping Ran, Jie Hou, Yi Zhang, Xianbo Wang · 2021 · Chinese Journal of Integrative Medicine
24. Temperature-sensitive hydrogel loaded with DNase I alleviates epidural fibrosis in a mouse model of laminectomy
    Jinpeng Sun, Gang Wang, Haoran Wang, Feng Hua, Zeyuan Song, Zhen Jin, Jun Liu, Hongliang Xin, Mingshun Zhang · 2022 · NPG Asia Materials
25. Complement Decay-Accelerating Factor is a modulator of influenza A virus lung immunopathology
    Nuno Brito Santos, Zoé Enderlin Vaz da Silva, Catarina Gomes, Celso Albuquerque Reis, Maria João Amorim · 2021 · PLoS Pathogens
26. Neutrophils and COVID-19
    Jasmin Šutković · 2025 · Progress in molecular biology and translational science
27. Neutrophil extracellular traps induced by neoadjuvant chemotherapy of breast cancer promotes vascular endothelial damage
    Linghui Kong, Song Hu, Ying Zhao, Yan Huang, Xiaobing Xiang, Yang Han Yu, Xiaochun Mao, Kangjie Xie, Xiaoyan Zhu, Pingbo Xu · 2025 · Breast Cancer Research
28. Neutrophil Spatiotemporal Regulatory Networks: Dual Roles in Tumor Growth Regulation and Metastasis
    Pengcheng Li, Feimu Fan, Bixiang Zhang, Chaoyi Yuan, Huifang Liang · 2025 · Biomedicines
29. Hypercoagulability and coronavirus disease 2019–associated hypoxemic respiratory failure: Mechanisms and emerging management paradigms
    Calvin H. Yeh, Kerstin de Wit, Jerrold H. Levy, Jeffrey Ian Weitz, Nima Vaezzadeh, Patricia C. Liaw, Alison Fox‐Robichaud, Karim Soliman, Paul Y. Kim · 2020 · The Journal of Trauma: Injury, Infection, and Critical Care
30. Interplay between Neutrophils, NETs and T-Cells in SARS-CoV-2 Infection—A Missing Piece of the Puzzle in the COVID-19 Pathogenesis?
    Paulina Niedźwiedzka‐Rystwej, Ewelina Grywalska, Rafał Hrynkiewicz, Dominika Bębnowska, Mikołaj Wołącewicz, Adam Majchrzak, Miłosz Parczewski · 2021 · Cells
31. Neutrophil-Lymphocyte Ratio Predicting Case Severity in SARS-CoV-2 Infection: A Review
    Sonal Agarwal · 2022 · Cureus
32. Effect of stimulated platelets in COVID-19 thrombosis: Role of alpha7 nicotinic acetylcholine receptor
    Lina Jankauskaitė, Mantas Malinauskas, Aušra Šnipaitienė · 2022 · Frontiers in Cardiovascular Medicine
33. Catalase Activity of IgGs of Patients Infected with SARS-CoV-2
    Anna S. Tolmacheva, Margarita K. Onvumere, Sergey E. Sedykh, Anna M. Timofeeva, Georgy A. Nevinsky · 2023 · International Journal of Molecular Sciences
34. Small airway disease in post-acute COVID-19 syndrome, a non-conventional approach in three years follow-up of a patient with long COVID: a case report
    Iván Chérrez-Ojeda, María F. Osorio, Karla Robles‐Velasco, Juan Carlos Calderón, Arturo Cortés-Telles, Jorge Zambrano, Cristian Guarderas, Belén Intriago, Laura Gochicoa‐Rangel · 2023 · Journal of Medical Case Reports
35. Autopsy Services and Emergency Preparedness of a Tertiary Academic Hospital Mortuary for the COVID-19 Public Health Emergency: The Yale Plan
    Declan McGuone, John H. Sinard, James R. Gill, Amanda Masters, Chen Liu, Raffaella A. Morotti, Vinita Parkash · 2020 · Advances in Anatomic Pathology
36. Combination therapy with plasma exchange and glucocorticoid may be effective for severe COVID‐19 infection: A retrospective observational study
    Yasushi Matsushita, Makio Kusaoi, Makoto Hiki, Goh Murayama, Yoshiyuki Abe, Kazuhisa Nozawa, Kazuhisa Takahashi, Ken Yamaji, Naoto Tamura, Toshio Naito · 2021 · Therapeutic Apheresis and Dialysis
37. Studies of mitochondrial and nuclear DNA released from food allergen‐activated neutrophils. Implications for non‐IgE food allergy
    Brigitte König, Anja N. Koch, Joseph A. Bellanti · 2021 · Allergy and Asthma Proceedings
38. COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases
    Yuanyuan Zhang, Mingjie Wang, Xian Zhang, Tianxiao Liu, Peter Libby, Guo-Ping Shi · 2021 · Cardiology Discovery
39. Corona Virus Disease 2019 (COVID-19) as a System-Level Infectious Disease With Distinct Sex Disparities
    Modjtaba Emadi‐Baygi, Mahsa Ehsanifard, Najmeh Afrashtehpour, Mahnaz Norouzi, Zahra Joz-Abbasalian · 2021 · Frontiers in Immunology
40. The “Elastic Perspective” of SARS-CoV-2 Infection and the Role of Intrinsic and Extrinsic Factors
    Federica Boraldi, Francesco Demetrio Lofaro, Andrea Cossarizza, Daniela Quaglino · 2022 · International Journal of Molecular Sciences
41. COVID 19 and febrile neutropenia: Case report and systematic review
    Taner Kaya, Ahmet Dilek, Reşat Özaras, Özlem Şahin Balçık, Hakan Leblebicioğlu · 2022 · Travel Medicine and Infectious Disease
42. COVID-19 pandemic: A multidisciplinary perspective on the pathogenesis of a novel coronavirus from infection, immunity and pathological responses
    Jia Yi, Jiameng Miao, Qingwei Zuo, Felix Owusu, Qiutong Dong, Peizhe Lin, Qilong Wang, Rui Gao, Xianbin Kong, Long Yang · 2022 · Frontiers in Immunology
43. Enoxaparin improves COVID-19 by reducing Neutrophils Extracellular Traps (NETs) production
    Emily da Silva Córneo, Flavio Protasio Veras, Giovanni Freitas Gomes, Ayda Henriques Schneider, Bruna Manuella, Cicero J. L. R. Almeida, Camila Meirelles Souza Silva, Ronaldo Bragança Martins Júnior, Sabrina Setembre Batah, Carla Sasso Simon et al. · 2023 · Clinical Immunology
44. Current status of COVID‐19 among hemodialysis patients in the East Azerbaijan Province of Iran
    Hamid Tayebi Khosroshahi, Alireza Mardomi, Bahram Niknafs, Farahnoosh Farnood, Mohsen Shekarchi, Shabnam Salehi, Taghi Fadaei Haggi · 2020 · Hemodialysis International
45. Unraveling the thread of uncontrolled immune response in COVID-19 and STEMI: an emerging need for knowledge sharing
    César Ríos‐Navarro, Elena de Dios, María J. Forteza, Vicente Bodı́ · 2021 · American Journal of Physiology-Heart and Circulatory Physiology
46. The clinical correlates of vaccine-induced immune thrombotic thrombocytopenia after immunisation with adenovirus vector-based SARS-CoV-2 vaccines
    Eleanor R. Gaunt, Neil Andrew Mabbott · 2021 · Immunotherapy Advances
47. Istradefylline, an adenosine A2a receptor antagonist, inhibits the CD4 + T-cell hypersecretion of IL-17A and IL-8 in humans
    Mieko Tokano, Masaaki Kawano, Rie Takagi, Sho Matsushita · 2022 · Immunological Medicine
48. Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis‘
    Elisa Gremese, Giovanni Brondani, Luca Apollonio, Gianfranco Ferraccioli · 2020 · Annals of the Rheumatic Diseases
49. Cholinergic and lipid mediators crosstalk in Covid-19 and the impact of glucocorticoid therapy
    Malena M. Pérez, Vinícius E. Pimentel, Carlos Alessandro Fuzo, Pedro Vieira Da Silva-Neto, Diana Mota Toro, Camila Oliveira Silva Souza, Thais Fernanda de Campos Fraga‐Silva, Luiz Gustavo Gardinassi, Jonatan C. S. de Carvalho, Nicola T. Neto et al. · 2021 · medRxiv
50. Structurally and functionally distinct early antibody responses predict COVID-19 disease trajectory and mRNA vaccine response
    Saborni Chakraborty, Joseph C. González, Benjamin Louis Sievers, Vamsee V. A. Mallajosyula, Srijoni Chakraborty, Megha Dubey, Usama Ashraf, Bowie Yik-Ling Cheng, Nimish D. Kathale, Kim Q.T. Tran et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
51. Neutrophil Extracellular Traps: Emerging Biomarker and Prototype of Functional Materials
    Bo Pang, Liping Wen, Linlin Zheng, Wei Ping Jia, Tengda Xu, Yongyang Song, Juan Li, Shutao Wang · 2025 · Advanced Functional Materials
52. Innate Immune Cells and Hypertension: Neutrophils and Neutrophil Extracellular Traps (NETs)
    Cameron Grant McCarthy, Piu Saha, Rachel M. Golonka, Camilla Ferreira Wenceslau, Bina Joe, Matam Vijay–Kumar · 2021 · Comprehensive physiology
53. Mesenchymal stem cell transplantation alleviated TBI-induced lung injury by inhibiting PAD4-dependent NET formation
    Jing Peng, Fengming Pan, Yu Xu, Yizhong Yan, Min Gao, Hongjing Zang, Ge Lin, Lamei Cheng, Yu Zhou · 2025 · Journal of Advanced Research
54. Road Map to Understanding SARS-CoV-2 Clinico-Immunopathology and COVID-19 Disease Severity
    Deepmala Karmakar, Basudev Lahiri, Piyush Ranjan, Jyotirmoy Chatterjee, Pooja Lahiri, Sanghamitra Sengupta · 2020 · Pathogens
55. Real-time observation of neutrophil extracellular trap formation in the inflamed mouse brain via two-photon intravital imaging
    Da Jeong Byun, Young Min Kim, Young‐Min Hyun · 2022 · Laboratory Animal Research
56. Complanatuside alleviates inflammatory cell damage induced by pro-inflammatory cytokines in skin keratinocytes
    Xiao Dan Wang, Xuetao Xu, Panpan Wu, Mengshuo Wu, Li‐She Gan, Jingwei Jin, Rihui Wu, Wenfeng Liu, Kun Zhang, Dongli Li et al. · 2022 · Frontiers in Chemistry
57. Epidemiology, pathogenesis, and management of Coronavirus disease 2019-associated stroke
    Lu Liu, Chenxia Zhou, Huimin Wei, Huimin Wei, Chen Zhou, Chen Zhou, Xunming Ji · 2023 · Frontiers of Medicine
58. Biomarkers of tissue remodelling are elevated in serum of COVID-19 patients who develop interstitial lung disease - an exploratory biomarker study
    Helene Wallem Breisnes, Diana Julie Leeming, M.A. Karsdal, Hannah Burke, Anna T. Freeman, Tom M. A. Wilkinson, Aishath Fazleen, Jannie Marie Bülow Sand · 2024 · BMC Pulmonary Medicine
59. COVID-19 Pneumonia and Cytokine Storm Syndrome
    Frank L. van de Veerdonk · 2024 · Advances in experimental medicine and biology
60. Selective phosphodiesterase 4 inhibitor roflumilast reduces inflammation and lung injury in models of betacoronavirus infection in mice
    Vinícius Amorim Beltrami, Flávia Rayssa Braga Martins, Débora Gonzaga Martins, Celso Martins Queiroz‐Junior, Franciel Batista Félix, Letícia Cassiano Resende, Felipe Rocha da Silva Santos, Larisse de Souza Barbosa Lacerda, Victor Rodrigues de Melo Costa, Walison Nunes da Silva et al. · 2025 · Inflammation Research
61. Comparing and Contrasting MERS, SARS-CoV, and SARS-CoV-2: Prevention, Transmission, Management, and Vaccine Development
    Mohammad Oves, Mithunan Ravindran, Mohd Ahmar Rauf, Mohammad Omaish Ansari, Maryam Zahin, Arun K. Iyer, Iqbal M.I. Ismail, Meraj Alam Khan, Nades Palaniyar · 2020 · Pathogens
62. Cutaneous Manifestations in SARS-CoV-2 Infection—A Series of Cases from the Largest Infectious Diseases Hospital in Western Romania
    Ruxandra Laza, Virgil Musta, Narcisa Nicolescu, Adelina Raluca Marinescu, Alexandra Herlo, Laura Vilceanu, Roxana Paczeyka, Talida Georgiana Cut, Voichița Elena Lăzureanu · 2021 · Healthcare
63. Thiotriazolin effectiveness in complex treatment of patients with post-COVID syndrome
    V. I. Kryvenko, M. Yu. Kolesnyk, Ігор Федорович Бєленічев, Sergii V. Pavlov · 2021 · Zaporozhye Medical Journal
64. Meso-Dihydroguaiaretic Acid Ameliorates Acute Respiratory Distress Syndrome through Inhibiting Neutrophilic Inflammation and Scavenging Free Radical
    Yen-Tung Lee, Yu‐Li Chen, Yi‐Hsuan Wu, Ih‐Sheng Chen, Hsun‐Shuo Chang, Yi‐Hsuan Wang, Shih-Hsin Chang, Yi‐Hsiu Wu, Ting‐I Kao, Huang‐Ping Yu et al. · 2022 · Antioxidants
65. Assessment of a cellular host response test to risk-stratify suspected COVID-19 patients in the Emergency Department setting
    Hollis R. O’Neal, Roya Sheybani, Terrell S. Caffery, Diana Hamer, Mark Laperouse, Mandi Wilkes Musso, Catherine S. O’Neal, Henry T. K. Tse, Ajay M. Shah, Christopher B. Thomas · 2022 · PLoS ONE
66. Triclocarban evoked neutrophil extracellular trap formation in common carp (Cyprinus carpio L.) by modulating SIRT3-mediated ROS crosstalk with ERK1/2/p38 signaling
    Siwen Li, Yanling Wang, Dongke Yu, Yuan Zhang, Xiali Wang, Mei Shi, Yanxin Xiao, Xinlian Li, Hongtao Xiao, Lu Chen et al. · 2022 · Fish & Shellfish Immunology
67. Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis as a Possible Side Effect of COVID-19 Vaccination
    Edva Noel, Urmiya Mamoon Rashid, Rizwan Rabbani, Waqas Ahmad Khan, Yves-Smith Benjamin, Iris Lee · 2022 · Cureus
68. Jusvinza, an anti-inflammatory drug derived from the human heat-shock protein 60, for critically ill COVID-19 patients. An observational study
    R Venegas-Rodriguez, Anabel Serrano Díaz, Ruben Peña-Ruiz, R Santana-Sanchez, Mabel Hernández-Cedeño, Aliusha Rittoles Navarro, Inti Grecesqui Cruz, Liam Manuel Pérez Aguilera, Anadys Segura-Fernández, Leticia del Rosario-Cruz et al. · 2023 · PLoS ONE
69. Functionality of immune cells in COVID-19 infection: development of cell-based therapeutics
    Maryam Sayahinouri, Sahar Mashayekhi Firouz, Amin Ebrahimi Sadrabadi, Mina Masoudnia, Mahnaz Abdolahi, Fatemeh Jafarzadeh, Meshkat Nouripour, Sana Mirzazadeh, Nazanin Zangeneh, Arsalan Jalili et al. · 2023 · Bioimpacts
70. Elective Joint Arthroplasty Should be Delayed by One Month After COVID-19 Infection to Prevent Postoperative Complications
    Enrico M. Forlenza, Joseph Serino, Matthew T. Weintraub, Robert Alexander Burnett, Vasili Karas, Craig J. Della Valle · 2023 · The Journal of Arthroplasty
71. ANCA-Associated Vasculitis after Moderna COVID-19 Vaccination
    Shiko Gen, Takanori Iwai, Sayuri Ohnari, Kanako Nobe, Naofumi Ikeda · 2023 · Case Reports in Nephrology
72. Comparing the expression of MiR-223-NLRP3-IL-1β axis and serum IL-1β levels in patients with severe COVID-19 and healthy individuals
    Sheyda Houshmandfar, Ali Khodadadi, Mohammad‐Reza Mahmoudian‐Sani, Roohangiz Nashibi, Mohammad Menati Rashno · 2023 · Immunobiology
73. Pathogenesis of Pulmonary Long COVID-19
    Alain Borczuk · 2023 · Modern Pathology
74. Neutrophils, NETs, NETosis and their paradoxical roles in COVID-19
    Khalid Ahmed Al‐Anazi, WK Al-Anazi, AM Al-Jasser · 2020 · Journal of Stem Cell Therapy and Transplantation
75. COVID-19 in cystic fibrosis patients
    E. Kondratyeva, Stanislav Aleksandrovich Krasovsky, Nataliya Y. Kashirskaya, E. Amelina, Elena Kestutisovna Zhekaite, Victoria Davidovna Sherman, Olga I. Simonova, Yu. V. Gorinova, Евгения Викторовна Бойцова, M. A. Mukhina et al. · 2020 · PULMONOLOGIYA
76. The Novel Aspirin as Breakthrough Drug for COVID-19: A Narrative Review
    Bamidele Johnson Alegbeleye, Oke-Oghene Philomena Akpoveso, Adewale James Alegbeleye, Rana Kadhim Mohammed, Eduardo Esteban Zubero · 2020 · Iberoamerican Journal of Medicine
77. Immunological Approaches to the Treatment of Novel Coronavirus Infection (Review)
    N. A. Lyubavina, С. Г. Сальцев, Меньков Николай Викторович, Тюрикова Любовь Валерьевна, С. С. Пластинина, Шония Моника Левановна, ALEXANDER A. TULICHEV, Милютина Марина Юрьевна, Е. В. Макарова · 2021 · Современные технологии в медицине
78. Correlation between α1-Antitrypsin Deficiency and SARS-CoV-2 Infection: Epidemiological Data and Pathogenetic Hypotheses
    Andrea Vianello, Gabriella Guarnieri, Fausto Braccioni, Béatrice Molena, Sara Lococo, Alessia Achille, Federico Lionello, Leonardo Salviati, Marco Caminati, Gianenrico Senna · 2021 · Journal of Clinical Medicine
79. The good, the bad and the ugly: G-CSF, ageing and neutrophils—Implications for severe COVID-19
    Daniel L Moss, Jay Rappaport · 2021 · Journal of Leukocyte Biology
80. Sweet syndrome in post-COVID-19 infection: A case report
    Fatima-Zahra Agharbi, Kenza Oqbani, Abire Allaoui, Inas Chikhaoui, Soumiya Chiheb · 2021 · Travel Medicine and Infectious Disease
81. A persistent neutrophil-associated immune signature characterises post-COVID19 pulmonary sequelae
    Peter Myles George, Anna K. Reed, Sujal R. Desai, Anand Devaraj, Tasnim Shahridan Faiez, Sarah Laverty, Michael Liu, Faisal Kamal, William D‐C Man, Sundeep Kaul et al. · 2022 · Research Square
82. RSV enhances Staphylococcus aureus bacterial growth in the lung
    Helen Eva Adams Rich, Simran Bhutia, Francina Gonzales de Los Santos, Gabrielle P Huizinga, Helen I. Warheit-Niemi, Stephen J. Gurczynski, Monica Bame, Michael T. Douglas, Susan B. Morris, Rachel L. Zemans et al. · 2024 · Infection and Immunity
83. Neutrophils Display Novel Partners of Cytosolic Proliferating Cell Nuclear Antigen Involved in Interferon Response in COVID-19 Patients
    Lucie Pesenti, Rodrigo de Oliveira Formiga, Nicola Tamassia, Elisa Gardiman, François Chable de la Héronnière, Sara Gasperini, Johana Chicher, Lauriane Kühn, Philippe Hammann, Morgane Le Gall et al. · 2025 · Journal of Innate Immunity
84. Lipid nanoparticles target neutrophils to reduce SARS-CoV-2-induced lung injury and inflammation
    Ha Eun Shin, Stefanos Giannakopoulos, Joo Dong Park, Hye Jung Jang, Chun Gwon Park, Sean V. Murphy, Juwon Park, Saguna Verma, Wooram Park · 2025 · Journal of Controlled Release
85. COVID-19 Organ Injury Pathology and D-Dimer Expression Patterns: A Retrospective Analysis
    Raluca Dumache, Camelia-Oana Mureșan, Sorina Maria Denisa Laitin, Nina Ivanovic, Adina Chisalita, Alexandra Herlo, Adelina Raluca Marinescu, Voichița Elena Lăzureanu, Talida Georgiana Cut · 2025 · Diagnostics
86. Can alpha‐linolenic acid be a modulator of “cytokine storm,” oxidative stress and immune response in SARS‐CoV‐2 infection?
    Danila Cianciosi, Yasmany Armas Díaz, Antonio Vittorino Gaddi, Fabio Capello, Maria Teresa Savo, Ramón del Jesús Palí Casanova, Julio César Martínez Espinosa, Alina Eugenia Pascual Barrera, María D. Navarro‐Hortal, Lingmin Tian et al. · 2023 · Food Frontiers
87. Taming the SARS-CoV-2-mediated proinflammatory response with BromAc®
    Geovane Marques Ferreira, Felipe Alves Clarindo, Ágata Lopes Ribeiro, Letícia Gomes de Pontes, Luciana Debortoli de Carvalho, Olindo Assis Martins‐Filho, Flávio Guimarães da Fonseca, Mauro Martins Teixeira, Adriano de Paula Sabino, Mathew Suji Eapen et al. · 2023 · Frontiers in Immunology
88. Exploring the mechanism of Radix Bupleuri in the treatment of depression combined with SARS-CoV-2 infection through bioinformatics, network pharmacology, molecular docking, and molecular dynamic simulation
    Zexing Chen, Xinhua Wang, Wanyi Huang · 2025 · Metabolic Brain Disease
89. Hydroxychloroquine against COVID-19: A critical appraisal of the existing evidence
    Konstantinos Tselios, Panagiotis Skendros · 2020 · European Journal of Rheumatology
90. The use of Thymaline to correct immune status deviations in COVID-19 (rationale for the use of drug and clinical case)
    S. А. Lukyanov, Kuznik Bi, Vladimir Kh. Khavinson, Константин Геннадьевич Шаповалов, Y. N. Smolyakov, Павел Петрович Терешков, Yu. K. Shapovalov, В. А. Коннов, Eli Magen · 2020 · Vrach
91. Fisiología de la hemostasia y su alteración por la coagulopatía en COVID-19
    Adriana Elizabeth González-Villalva, Aurora de la Peña-Dı́az, Marcela Rojas Lemus, Nelly López-Valdéz, Martha Ustarroz-Cano, Isabel García‐Peláez, Patricia Bizarro‐Nevares, Teresa I. Fortoul van der Goes · 2020 · Revista de la Facultad de Medicina UNAM
92. Virology, Immunity and Vaccine Development of SARS-CoV-2
    Sidre Erganiş, Gülendam Bozdayı · 2021 · Archives of Current Medical Research
93. COVID-19 and immune-mediated inflammatory rheumatic diseases
    E. L. Nasonov · 2021 · Clinical pharmacology and therapy
94. Preinfection laboratory parameters may predict COVID‐19 severity in tumor patients
    Alexander Kiani, Romina Roesch, Clemens‐Martin Wendtner, Frank Kullmann, Thomas Kubin, Thomas Südhoff, Marinela Augustin, Markus Andreas Schaich, Clemens Müller‐Naendrup, Gerald Illerhaus et al. · 2021 · Cancer Medicine
95. Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath
    Kate Chander Chiang, John G. Rizk, Deanna J. Nelson, Lakshmanan Krishnamurti, Selvakumar Subbian, John D. Imig, Imran Khan, Srinivasa T. Reddy, Ajay Gupta · 2022 · Expert Opinion on Therapeutic Targets
96. Distribution of Interferon Lambda 4 Single Nucleotide Polymorphism rs11322783 Genotypes in Patients with COVID-19
    Leonardo Sorrentino, Valentina Silvestri, Giuseppe Oliveto, Mirko Scordio, Federica Frasca, Matteo Fracella, Camilla Bitossi, Alessandra D’Auria, Letizia Santinelli, Lucia Gabriele et al. · 2022 · Microorganisms
97. Mycotic infection as a risk factor for COVID-19: A meta-analysis
    Anlin Liu, Zhengtu Li, Guansheng Su, Ya Li, Yuzhuo Zhang, Jinkai Liang, Xiaoxue Cheng, Xidong Wang, Yongming Li, Feng Ye · 2022 · Frontiers in Public Health
98. A Pleomorphic Puzzle: Heterogeneous Pulmonary Vascular Occlusions in Patients with COVID-19
    Jeeshan Singh, Irmgard Herrmann, Aparna Mahajan, Christine Schauer, Xiaomei Shan, Arndt Hartmann, Ralf J. Rieker, Katja Evert, Christina Falkeis, Elisabeth Naschberger et al. · 2022 · International Journal of Molecular Sciences
99. The Prognostic Utility of Cytokines in Hospitalized COVID-19 Patients
    Ákos Vince Andrejkovits, Adina Huţanu, Ervin József Susányi, Valentina Negrea, Anca-Meda Văsieșiu · 2023 · The Journal of Critical Care Medicine
100. Factors Associated with Mortality Among Severe Omicron Patients for COVID-19
     Shuting Wu, Guichan Liao, Junqin Mao, Haiming Yan, Juanjuan Chen, Jie Peng · 2024 · Infection and Drug Resistance